Varda Space Industries

Thesis

Varda Space Industries has returned five capsules to Earth, more than any other in-space manufacturer. Series C raised $187M (July 2025) from Founders Fund, Peter Thiel, and Khosla Ventures. Total funding approaches $578M. They hold an FAA Part 450 license valid through 2029. Revenue comes from DoD hypersonic reentry testing contracts. Varda's approach is to manufacture products in microgravity (pharmaceuticals, fiber optics) and return them to Earth. The five successful reentries demonstrate genuine operational capability in the most difficult part of the space manufacturing value chain. The investor roster. Founders Fund, Peter Thiel, Khosla Ventures. Is among the strongest in the space sector. $578M total funding provides substantial runway. The FAA Part 450 license is a significant regulatory moat. Still private. The company's operational track record and DoD revenue suggest it could be an IPO candidate once commercial manufacturing revenue scales. Watch for a pre-IPO round or S-1 filing.

Catalysts

• +Five successful capsule reentries. Most of any in-space manufacturer
• +FAA Part 450 license valid through 2029 provides regulatory moat
• +DoD hypersonic reentry testing contracts generating revenue

Risks

• -In-space manufacturing is unproven at commercial scale. Unit economics unclear
• -Private at $578M total funding. Likely at a high valuation for new investors
• -Space manufacturing faces enormous technical risks with each launch/reentry cycle

Common questions